Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma.
Saved in:
| Title: | Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma. |
|---|---|
| Authors: | Shih BB; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Ma C; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Cortes JR; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA., Reglero C; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Miller H; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Quinn SA; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Albero R; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Biomedical Research Institute August Pi y Sunyer (IDIBAPS), Barcelona, Spain., Laurent AP; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Mackey A; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Ferrando AA; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA; Department of Pediatrics, Columbia University Medical Center, New York, New York, USA; Department of Systems Biology, Columbia University Medical Center, New York, New York, USA., Geskin L; Department of Medicine, Columbia University Medical Center, New York, New York, USA., Palomero T; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. Electronic address: tp2151@cumc.columbia.edu. |
| Source: | The Journal of investigative dermatology [J Invest Dermatol] 2024 Jul; Vol. 144 (7), pp. 1579-1589.e8. Date of Electronic Publication: 2024 Jan 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38219917 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shih+BB%22">Shih BB</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ma+C%22">Ma C</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Cortes+JR%22">Cortes JR</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Reglero+C%22">Reglero C</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Miller+H%22">Miller H</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Quinn+SA%22">Quinn SA</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Albero+R%22">Albero R</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Biomedical Research Institute August Pi y Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Laurent+AP%22">Laurent AP</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Mackey+A%22">Mackey A</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ferrando+AA%22">Ferrando AA</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA; Department of Pediatrics, Columbia University Medical Center, New York, New York, USA; Department of Systems Biology, Columbia University Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Geskin+L%22">Geskin L</searchLink>; Department of Medicine, Columbia University Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Palomero+T%22">Palomero T</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. Electronic address: tp2151@cumc.columbia.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220426720%22">The Journal of investigative dermatology</searchLink> [J Invest Dermatol] 2024 Jul; Vol. 144 (7), pp. 1579-1589.e8. <i>Date of Electronic Publication: </i>2024 Jan 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0426720 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-1747 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220022202X%22">0022202X </searchLink><i>NLM ISO Abbreviation: </i>J Invest Dermatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38219917 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jid.2023.12.010 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1579 Titles: – TitleFull: Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shih BB – PersonEntity: Name: NameFull: Ma C – PersonEntity: Name: NameFull: Cortes JR – PersonEntity: Name: NameFull: Reglero C – PersonEntity: Name: NameFull: Miller H – PersonEntity: Name: NameFull: Quinn SA – PersonEntity: Name: NameFull: Albero R – PersonEntity: Name: NameFull: Laurent AP – PersonEntity: Name: NameFull: Mackey A – PersonEntity: Name: NameFull: Ferrando AA – PersonEntity: Name: NameFull: Geskin L – PersonEntity: Name: NameFull: Palomero T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2024 Jul Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1523-1747 Numbering: – Type: volume Value: 144 – Type: issue Value: 7 Titles: – TitleFull: The Journal of investigative dermatology Type: main |
| ResultId | 1 |